Internal Medicine, Cardiovascular Disease · South Bend, IN
NPI
1093704801
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
211 N Eddy St
South Bend, IN, 46617
Phone (574) 239-1433
Groups this clinician bills Medicare through
Medicare paid, 2024
$390K
10,711 services
Medicare patients, 2024
1,675
Average age 76
Drug cost, 2024
$1.7M
13,294 prescriptions
Company payments, 2025
$335
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmed A Abdel-Latief was code 93000 (electrocardiogram), 1,870 times for 1,106 patients. In total Ahmed A Abdel-Latief billed 10,711 services in 100 codes, and Medicare paid $390K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 1,870 | 1,106 | $8.89 | $17K |
| 99214 Office E&M - Established | Office | 897 | 493 | $84.25 | $76K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 870 | 492 | $11.71 | $10K |
| 93306 Echocardiography (TTE/TEE) | Office | 608 | 587 | $121.11 | $74K |
| 36415 Venipuncture Blood Collection | Office | 570 | 359 | $8.59 | $4,895 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 532 | 133 | $6.08 | $3,233 |
| 83735 Clinical Chemistry | Office | 470 | 346 | $6.54 | $3,073 |
| 85025 Blood Count | Office | 441 | 329 | $7.58 | $3,345 |
| 80053 Clinical Chemistry | Office | 413 | 318 | $10.33 | $4,266 |
| 84443 Clinical Chemistry | Office | 397 | 315 | $16.39 | $6,508 |
| 82550 Clinical Chemistry | Office | 389 | 301 | $6.34 | $2,467 |
| 80061 Clinical Chemistry | Office | 370 | 300 | $13.01 | $4,813 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 351 | 177 | $85.19 | $30K |
| 93015 Electrocardiogram | Office | 235 | 223 | $44.28 | $10K |
| 82306 Clinical Chemistry | Office | 199 | 178 | $29.01 | $5,773 |
By year: 2022 $384K for 9,567 services; 2023 $267K for 6,920 services; 2024 $390K for 10,711 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 570 | 359 | $8.59 | $4,895 |
| 83735 Clinical Chemistry | 470 | 346 | $6.54 | $3,073 |
| 85025 Blood Count | 441 | 329 | $7.58 | $3,345 |
| 80053 Clinical Chemistry | 413 | 318 | $10.33 | $4,266 |
| 84443 Clinical Chemistry | 397 | 315 | $16.39 | $6,508 |
| 82550 Clinical Chemistry | 389 | 301 | $6.34 | $2,467 |
| 80061 Clinical Chemistry | 370 | 300 | $13.01 | $4,813 |
| 82306 Clinical Chemistry | 199 | 178 | $29.01 | $5,773 |
| 82607 Clinical Chemistry | 104 | 101 | $14.78 | $1,537 |
| 85610 Clinical Chemistry | 74 | 33 | $4.20 | $311 |
Medicare prescription drug claims, 2024
In 2024, the drug Ahmed A Abdel-Latief prescribed most often to Medicare patients was Clopidogrel (Clopidogrel Bisulfate), with 1,167 prescriptions and refills. In total Ahmed A Abdel-Latief wrote 13,294 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clopidogrel Clopidogrel Bisulfate | 1,167 | 3,332 | 368 | $11K |
| Atorvastatin Calcium Generic | 1,039 | 2,997 | 336 | $8,310 |
| Amlodipine Besylate Generic | 928 | 2,661 | 306 | $5,333 |
| Rosuvastatin Calcium Generic | 901 | 2,539 | 280 | $8,895 |
| Eliquis Apixaban | 898 | 1,706 | 239 | $971K |
| Carvedilol Generic | 671 | 1,920 | 216 | $5,223 |
| Sotalol Sotalol Hcl | 576 | 1,669 | 186 | $13K |
| Irbesartan Generic | 566 | 1,616 | 155 | $7,743 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 551 | 1,527 | 190 | $10K |
| Metoprolol Succinate Generic | 493 | 1,391 | 186 | $5,848 |
| Furosemide Generic | 491 | 1,362 | 189 | $2,434 |
| Metoprolol Tartrate Generic | 422 | 1,224 | 141 | $2,071 |
| Lisinopril Generic | 342 | 1,012 | 110 | $2,430 |
| Hydralazine Hcl Generic | 324 | 907 | 110 | $3,832 |
| Spironolactone Generic | 287 | 833 | 103 | $1,876 |
Brand drugs: 1,546 claims; generic drugs: 11,748 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmed A Abdel-Latief $335 ($335 in general payments such as food, travel and fees) from 9 companies. The largest payer was Novartis Pharmaceuticals Corporation with $140.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 8 | $140 |
| Pfizer Inc. PFE | 3 | $43.59 |
| Abbott Laboratories ABT | 1 | $30.65 |
| Boston Scientific Corporation BSX | 1 | $28.75 |
| Scpharmaceuticals Inc. SCPH | 1 | $22.36 |
| Daiichi Sankyo Inc. 4568.T | 1 | $19.9 |
| Esperion Therapeutics, Inc. ESPR | 1 | $17.63 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $16.67 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.